DynoChem User Meeting 2009: Theme - Achieve Quality by Design

The DynoChem User Meeting is an event focused on the batch industries, especially pharmaceutical API synthesis.

The 2009 meeting took place in Philadelphia on 13-14 May and was an outstanding success. Outline Program information for 2009 is given below.

If you are a member of our Users Area (DynoChem Resources), you can also download the abstracts and/or the distributable presentations.

Program:

• David am Ende, Pfizer:
  Process Design for Continuous Flow Manufacturing of Pharmaceutical APIs
• Viviane Massonneau, Merck:
  How Process Safety and Environmental lab can guide Process Development
• Paul Stonestreet, GSK:
  Roles of mechanistic and empirical modeling/DOE in achieving Quality by Design
• Jean Tom, BMS:
  The Changing Role of Process Engineering in Pharma.
• Danielle Adams, GSK:
  Pilot Plant Unit Operations Modelling as a Process Scale Tool
• Rich Ballenger, Abbott:
  Practical Insight on New Model Development: Filtration and Centrifugation
• Dharmesh Bhanushali, GSK:
  An Example from GSK's Design for Manufacture Initiative: Use of Dynochem in Conjuction with Lab and Pilot Scale Data to Advance Process Understanding
• Ed Casanova, Monsanto:
  Extracting kinetic coefficients with DynoChem for three parallel reactions from dynamic operation of a Gas-Liquid-Liquid reactor typically used in continuous operation
• Carolyn Cummings, Amgen:
  Practical Applications of Distillation Modeling in DynoChem
• David Erdman, Pfizer:
  DynoChem Modelling of 3 Continuous Stirred Tank Reactors
• Steve Eyley, AstraZeneca:
  Why Study a Synthetically Useless Reaction? - Unravelling Sulphonate Ester Formation using DynoChem
• Dan Hallow, BMS:
  Application of DynoChem Reaction Modeling to Quality by Design
• Matt Jorgensen, Pfizer:
  Modeling is the Easy Part ! : Getting the right data and getting the data right is the challenging part!
• Jeff Niemeier, Eli Lilly:
  Using DynoChem to Scale Up Data from Various Calorimeters
• Roberto Novoa, Chemagis:
  Optimization and Scale Up of chemical reaction during an API project development
• Jason Nyrop, Merck:
  Development of a high performance, company specific DynoChem front-end
• David Place, Wyeth:
  Using DynoChem to determine a suitable sampling endpoint for reaction analysis in a DoE
• Steve Richter, Abbott:
  DynoChem Applications in Abbott's Process Safety Laboratory
• Praveen Sharma, BMS:
  Pressure Filtration and Centrifuge Modeling in DynoChem
• Jim Vernille, BMS:
  Successes and Challenges in Constructing a Crystallization Model for Prediction of Supersaturation and Crystal Size from Initial Seed Distributions.